Navigation Links
Prof. Dr. George Gettinby Honored With Dieter Lutticken Award
Date:5/19/2008

BOXMEER, Netherlands, May 19 /PRNewswire/ -- At the "World Aquaculture 2008", held on May 19-23 in Busan, Korea, Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom, was honored with the Intervet Dieter Lutticken Award for his innovative statistical and epidemiological research methods in sea-lice treatments in salmon farming. The jury found his research methods an excellent example of commitment to the advancement of reducing, refining and replacing the use of animals in research, development and production of veterinary medicines.

Prof. Dr. George Gettinby's research focused on the application of statistical and epidemiological methods in sea-lice treatments in salmon farming in order to minimize the number of animals required in test groups. Gettinby's research also provides an alternative to assessing the effectiveness of veterinary medicines in fish, which supports the replacement principle. This alternative is the adoption of mathematical models which can simulate the effects of treatments on lice populations.

Dr. Dieter Lutticken, who presented the award, with a prize fund of 20,000 Euro said: "There has been a long and intimate relationship between life sciences and statistics. Prof. Gettinby's innovative statistical and epidemiological research methods are an excellent example of refining and reducing the use of animals in sea-lice treatments in salmon farming. I am pleased that we can honor Prof. Gettinby at the World Aquaculture Conference today."

The panel of jury experts praised "Prof. Dr. Gettingby's innovating mathematical model approach for investigating the optimal use of treatments and one which involves minimal use of animals. In addition, these methods also minimize the use of veterinary medicines in the environment."

Prof. Gettinby said: "I am honored to receive the Dieter Lutticken Award and it is pleasing to know that the Award has come as a result of the increasing role of statistics and mathematical modelling in the pursuit of medicines for animals and the improved health of species in aquaculture. In accepting this award, I gratefully acknowledge the collaboration, support and work of the Marine Harvest Ltd, Scottish Quality Salmon, the UK Department for Environment, Food and Rural Affairs and the Epi-informatics research group at the University of Strathclyde."

The Dieter Lutticken award, established in 2004, aims to encourage research into the use of alternative models for animal testing with significant impact on the development or production of new animal health products. Intervet/Schering-Plough Animal Health welcomes submissions from scientists and public life-science institutions. The euro 20,000 award is named after Dr. Dieter Lutticken, a committed researcher in microbiology and virology. He guided and shaped Intervet's R&D for more than a quarter of a century. Dr. Lutticken retired in 2003 from his position as Vice President and Head of R&D.

The award's scope covers in vitro models used in R&D which replace animal testing for licensing purposes as well as studies avoiding the use of animals in efficacy, safety and quality testing in the production of biologicals and pharmaceuticals for animals.

A jury panel composed of experts from public institutions of the animal health/animal testing sector and Intervet representatives looks for possible candidates and makes the final selection. Intervet also welcomes submissions from all life-science research institutions. Commercial organizations are excluded. For more information on applications, please contact Global Communications, Animal Health, Boxmeer, The Netherlands (communications@intervet.com). This year's deadline is November 15, 2008.

Note for the editor

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its website is http://www.schering-plough.com.

For more information about Intervet/Schering-Plough Animal Health visit the following website: http://www.intervet.com http://www.spah.com


'/>"/>
SOURCE Schering-Plough
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ready: UH prof. chronicles phenomenon of new later motherhood
2. AlphaMed Press Names George Kendall Vice President, Operations and Business Development
3. Georgetown researchers find stem cell marker controls 2 key cancer pathways
4. George Institute receives Gates Foundation grant to survey funding flows
5. Georgetown U student selected for prestigious Bouchet Society
6. Home Oxygen Community Applauds Senator George Voinovich for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
7. American Tailgaters Association, ESPNs Sean Salisbury and George Foreman Unite in the Fight Against Pediatric Cancers Around Super Bowl XLII
8. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
9. Photo: MultiVu Promotes George DeTorres to Divisional Vice President for the MultiVu Healthcare Team
10. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
11. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... ... The iaedp Foundation, the premier provider of educational programs and training standards for ... spectrum of disordered eating, announced today that the 2017 Symposium set a new attendance ... several countries converged on the Green Valley Resort in Las Vegas. , “We ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... 24, 2017 , ... Empower Brokerage, located in Southlake, Texas, ... programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program ... to teach how to maximize their sales efforts, as well as how to ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Communion ... real people of God in congregations across the United States. “The Communion ... ordained in 1964 who has served congregations in seven states throughout his long ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... ShangPharma, a leading life science ... development and discovery services, technology, and investment ... today the intent for a strategic corporate ... the Contract Research Organizations (CRO) and Contract ... entities include ChemPartner Shanghai, ChemPartner Fengxian, ChemPartner ...
(Date:3/24/2017)... 24, 2017 Research and Markets has announced ... Diagnostics, 2017 - 2035" report to their offering. ... The Deep Learning: Drug Discovery ... outlook of the growing market of deep learning solutions within the ... algorithms have emerged as a novel solution to generate relevant insights ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , ... are provided for the period 2015 through 2022. Also, a six-year historic ...
Breaking Medicine Technology: